509 filings
Page 18 of 26
6-K
vd0uav9j
26 Jul 21
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014
10:51am
6-K
3aqiiu7us86bbad0l
21 Jul 21
Conference Call Alert
4:06pm
6-K
8ev9dx1ci
16 Jul 21
Current report (foreign)
2:39pm
6-K
vtzt1ubs98i1 iytbb
15 Jul 21
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology
6:22am
6-K
n5ajotnsmrbur kfayj
1 Jul 21
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of
11:02am
6-K
7g8y5
25 Jun 21
Current report (foreign)
10:47am
6-K
1uyvws ah9
17 Jun 21
MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals
6:16am
6-K
ahztdnht
7 Jun 21
Current report (foreign)
1:21pm
6-K
550uml
4 Jun 21
Presentation will be available on demand as part of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
3:04pm
6-K
kub7qy1siursblesdgb9
2 Jun 21
Current report (foreign)
12:06pm
6-K
fw9fcningn1d
21 May 21
MorphoSys To Participate in UBS Global Healthcare Conference
10:43am
6-K
30cujs4 j4qshwx
20 May 21
Annual General Meeting on 19.05.2021
1:16pm
6-K
m853v4eqcatqjb1e06
20 May 21
MorphoSys to Present Data on Tafasitamab (Monjuvi®) at the 2021 ASCO Annual Meeting
6:30am
6-K
unjle3zybxqwmm3
12 May 21
MorphoSys and Incyte Announce First Patient Dosed in Phase 3
6:19am
6-K
0oleyouvda
6 May 21
MorphoSys AG Reports First Quarter 2021 Results
1:13pm
6-K
ls3hx5f
5 May 21
First Quarter Interim Statement
4:21pm
6-K
pbj9kqmg28ax7f
29 Apr 21
Conference Call Alert
8:38am
6-K
t17 qrznp8oqd
20 Apr 21
Current report (foreign)
6:14am
6-K
a0fo vz5h781
15 Apr 21
Current report (foreign)
6:11am
6-K
kt3tfcbzvui921
24 Mar 21
Current report (foreign)
12:48pm